Pulmonary Hypertension Linked to Mortality After Atrial Septal Defect Repair
Persistent pulmonary hypertension is strong predictor of mortality in older patients who underwent ASD closure.
All articles by Cardiology Advisor Contributing Writer
Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH
For patients with inoperable or residual postendarterectomy chronic thromboembolic pulmonary hypertension, performing a balloon pulmonary angioplasty provided improvements in pressure measurements, functional class, and exercise capacity with an acceptable risk profile.
Effect of Delayed vs Immediate Interventions in Transient STEMI
This was the first randomized controlled trial comparing a delayed vs immediate invasive strategy in patients with transient STEMI.
Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF
Investigators sought to determine the effect of serelaxin infusion on incidence of death from cardiovascular causes at 180 days in patients hospitalized for acute heart failure.
Barriers to Primary Care Coverage Persist After ACA Implementation
Barriers to primary care coverage and access still exist for a significant number of people despite coverage expansions following enactment of the Affordable Care Act, according to a study published in Health Equity.
BNP Molar Ratio Changes Precede Worsening Renal Function in Acute HF
Researchers examined whether the difference in the circulating levels of each brain natriuretic peptide molecular form is related to the incidence of worsening renal function in acute heart failure.
Using Heart Rate and Premature Atrial Contractions to Predict Atrial Fibrillation
Investigators analyzed the relationship among low heart rate at 24hECG, premature atrial contractions, and incident atrial fibrillation in a prospective population-based cohort.
Pharmacodynamics of Adjunctive Vorapaxar With DAPT in Type 2 Diabetes
Investigators examined the effects of vorapaxar on thrombotic cardiovascular events in patients with atherosclerotic disease and type 2 diabetes.
Evolocumab Rapidly Reduces LDL-C When Added to High-Intensity Statin in ACS
Researchers evaluated how feasible, safe, and effective evolocumab is at lowering low-density lipoprotein cholesterol when initiated in patients hospitalized with acute coronary syndrome.
Novel Risk Model Predicts Sudden Cardiac Death Risk in Childhood HCM
Investigators sought to create a risk prediction tool for sudden cardiac death in children with childhood hypertrophic cardiomyopathy.
Next post in Pediatric Cardiology
